These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 8036027
1. New therapeutic agents marketed in 1993. Hussar DA. Pa Med; 1994 May; 97(5):12-7. PubMed ID: 8036027 [Abstract] [Full Text] [Related]
2. New therapeutic agents marketed in 1993. Hussar DA. Pa Med; 1994 Apr; 97(4):12-6. PubMed ID: 8008381 [Abstract] [Full Text] [Related]
3. New therapeutic agents marketed in 1993. Hussar DA. Pa Med; 1994 Jun; 97(6):22-3. PubMed ID: 8065777 [Abstract] [Full Text] [Related]
4. New therapeutic agents marketed in 1993. Hussar DA. Pa Med; 1994 Jul; 97(7):16-8. PubMed ID: 7936695 [Abstract] [Full Text] [Related]
5. New therapeutic agents marketed in 1995. Hussar DA. Pa Med; 1996 Apr; 99(4):43-6. PubMed ID: 8935886 [Abstract] [Full Text] [Related]
8. Canadian and US drug approval times and safety considerations. Rawson NS, Kaitin KI. Ann Pharmacother; 2003 Oct; 37(10):1403-8. PubMed ID: 14519031 [Abstract] [Full Text] [Related]
10. Patent life of antiretroviral drugs approved in the US from 1987 to 2007. Rodriguez-Monguio R, Seoane-Vazquez E. AIDS Care; 2009 Jun; 21(6):760-8. PubMed ID: 19499381 [Abstract] [Full Text] [Related]
15. A comparison of new drug availability in Canada and the United States and potential therapeutic implications of differences. Lexchin J. Health Policy; 2006 Dec; 79(2-3):214-20. PubMed ID: 16472888 [Abstract] [Full Text] [Related]
16. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Proposed rule. Fed Regist; 1998 Jun 08; 63(109):31143-61. PubMed ID: 10180130 [Abstract] [Full Text] [Related]